• Je něco špatně v tomto záznamu ?

Rosuvastatin, Perindopril and Ezetimibe loaded instant release buccal films: Development and in vitro characterization

Sobia Anwar, Muhammad Zaman, Maria Abdul Ghafoor Raja, Asif Mahmood, Muhammad Wahab Amjad

. 2020 ; 18 (4) : 115-125.

Jazyk angličtina Země Česko

Typ dokumentu klinická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc21009076

Background: Rosuvastatin Calcium and Ezetimibe are used to control cholesterol level while Perindopril Erbumine is used to treat hypertension. Hepatic metabolism reduces the therapeutic effect of these drugs. Objective: Instant release buccal films (IRBFs) could possibly be a solution to this issue. The objective of the study was to formulate IRBFs of Rosuvastatin Calcium, Perindopril Erbumine and Ezetimibe using solvent casting technique. Methods: Polymers used to prepare IRBFs included hydroxypropyl methylcellulose (HPMC E5), PEG 400 (as plasticizer) and Tween 80 (as surfactant). Solvent casting technique was used to fabricate the films, followed by their in-vitro analysis including high performance liquid chromatography (HPLC), X-ray diffraction (XRD), fourier transform infrared evaluation (FTIR), In-vitro dissolution, In-vitro disintegration, stability tests, scanning electron microscopy (SEM), folding fortitude, thickness evaluation, surface pH, tensile strength, weight variation and percentage moisture content. Results: Optical microscopy as well as SEM analysis displayed that the surfaces of IRBFs were smooth with uniform mixing of ingredients. IRBFs disintegrated within 15 seconds while on dissolution they exhibited instant drug release i.e. 100% release in 2 minutes. Conclusions: The results show promising potential of IRBFs in drug delivery.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21009076
003      
CZ-PrNML
005      
20211022223022.0
007      
ta
008      
210331s2020 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.32725/jab.2020.015 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Anwar, Sobia $u The University of Lahore, Faculty of Pharmacy, Department of Pharmaceutics, Lahore, Pakistan
245    10
$a Rosuvastatin, Perindopril and Ezetimibe loaded instant release buccal films: Development and in vitro characterization / $c Sobia Anwar, Muhammad Zaman, Maria Abdul Ghafoor Raja, Asif Mahmood, Muhammad Wahab Amjad
504    __
$a Literatura
520    9_
$a Background: Rosuvastatin Calcium and Ezetimibe are used to control cholesterol level while Perindopril Erbumine is used to treat hypertension. Hepatic metabolism reduces the therapeutic effect of these drugs. Objective: Instant release buccal films (IRBFs) could possibly be a solution to this issue. The objective of the study was to formulate IRBFs of Rosuvastatin Calcium, Perindopril Erbumine and Ezetimibe using solvent casting technique. Methods: Polymers used to prepare IRBFs included hydroxypropyl methylcellulose (HPMC E5), PEG 400 (as plasticizer) and Tween 80 (as surfactant). Solvent casting technique was used to fabricate the films, followed by their in-vitro analysis including high performance liquid chromatography (HPLC), X-ray diffraction (XRD), fourier transform infrared evaluation (FTIR), In-vitro dissolution, In-vitro disintegration, stability tests, scanning electron microscopy (SEM), folding fortitude, thickness evaluation, surface pH, tensile strength, weight variation and percentage moisture content. Results: Optical microscopy as well as SEM analysis displayed that the surfaces of IRBFs were smooth with uniform mixing of ingredients. IRBFs disintegrated within 15 seconds while on dissolution they exhibited instant drug release i.e. 100% release in 2 minutes. Conclusions: The results show promising potential of IRBFs in drug delivery.
650    _2
$a lidé $7 D006801
650    _2
$a rosuvastatin kalcium $x aplikace a dávkování $7 D000068718
650    _2
$a perindopril $x aplikace a dávkování $7 D020913
650    _2
$a ezetimib $x aplikace a dávkování $7 D000069438
650    _2
$a techniky in vitro $7 D066298
650    _2
$a biofilmy $x účinky léků $7 D018441
650    _2
$a obličej $x patologie $7 D005145
650    _2
$a hypercholesterolemie $x farmakoterapie $7 D006937
650    _2
$a hypertenze $x farmakoterapie $7 D006973
650    12
$a aplikace bukální $7 D000278
650    12
$a uvolňování léčiv $7 D065546
650    _2
$a biomedicínské a zubní materiály $x analýza $x terapeutické užití $7 D001697
650    _2
$a vysokoúčinná kapalinová chromatografie $x metody $x statistika a číselné údaje $7 D002851
650    _2
$a histologické techniky $7 D006652
650    _2
$a statistika jako téma $7 D013223
653    00
$a bukální filmy
653    00
$a gravimetrie
655    _2
$a klinická studie $7 D000068397
700    1_
$a Zaman, Muhammad $u The University of Lahore, Faculty of Pharmacy, Department of Pharmaceutics, Lahore, Pakistan; University of Central Punjab, Faculty of Pharmacy, Department of Pharmaceutics, Lahore, Pakistan
700    1_
$a Raja, Maria Abdul Ghafoor
700    1_
$a Mahmood, Asif $u The University of Lahore, Faculty of Pharmacy, Department of Pharmaceutics, Lahore, Pakistan
700    1_
$a Amjad, Muhammad Wahab $u Northern Border University, Faculty of Pharmacy, Department of Pharmaceutics, Rafha, Kingdom of Saudi Arabia
773    0_
$t Journal of applied biomedicine $x 1214-021X $g Roč. 18, č. 4 (2020), s. 115-125 $w MED00012667
910    __
$a ABA008 $b B 2301 $c 1249 $y p $z 0
990    __
$a 20210331111905 $b ABA008
991    __
$a 20211022223030 $b ABA008
999    __
$a ok $b bmc $g 1637298 $s 1129438
BAS    __
$a 3
BMC    __
$a 2020 $b 18 $c 4 $d 115-125 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
LZP    __
$c NLK189 $d 20211022 $a NLK 2021-15/dk

Najít záznam

Citační ukazatele

Možnosti archivace